Solubility and transdermal permeation properties of a dehydroepiandrosterone cyclodextrin complex from hydrophilic and lipophilic vehicles.
The permeation ability of a compound is due principally to its concentration in the vehicle and to its aptitude to cross the stratum corneum of the skin. In this work ex-vivo permeation studies on newly developed formulations containing dehydroepiandrosterone (DHEA) were carried out to investigate vehicles that increase drug permeation through the skin. To enhance the solubility of DHEA, its complex form with alpha-cyclodextrin was used. In addition, the two forms (pure drug and complex form) were introduced in hydrophilic (water), lipophilic (paraffin oil), and microemulsion vehicles to evaluate the synergic effect of cyclodextrins and microemulsion vehicles on solubility and permeation. From the results, DHEA solubility is notably conditioned by the type of the vehicle used: the highest solubilities (both for pure and complex drug forms) were obtained with microemulsion, followed by paraffin oil and water. Moreover, in all the studied vehicles, the c-DHEA was more soluble than DHEA. Permeation profile fluxes showed very interesting differences. That reflect the varying drug forms (pure drug and complex form), vehicles used, and drug concentrations in the vehicles. The major flux was obtained in complex of DHEA with alpha-cyclodextrins in the microemulsion vehicle. Therefore, this type of vehicle and drug form would be very useful in the development of a topical formulation containing DHEA.
Ceschel
GianCarlo
G
Department of Pharmaceutical Science, University of Bologna, Bologna, Italy. ceschel@biocfarm.unibo.it
Bergamante
Valentina
V
Maffei
Paola
P
Lombardi Borgia
Simone
S
Calabrese
Valeria
V
Biserni
Stefano
S
Ronchi
Celestino
C
D000818:Animals; D003687:Dehydroepiandrosterone / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D008297:Male; D010539:Permeability; D014677:Pharmaceutical Vehicles; D012867:Skin / Q000378:metabolism*; D012995:Solubility; D013552:Swine; D047391:alpha-Cyclodextrins / Q000008:administration & dosage*
D014677:Pharmaceutical Vehicles; D047391:alpha-Cyclodextrins; D003687:Dehydroepiandrosterone; C032613:alpha-cyclodextrin